{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:09:07Z","timestamp":1790291347014,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Inhaled corticosteroids (ICS) are key treatments for controlling asthma and preventing asthma attacks. However, the responsiveness to ICS varies among individuals. MicroRNAs (miRNAs) have been lauded for their prognostic utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We hypothesized that circulating miRNAs obtained at baseline\/prerandomization in the Childhood Asthma Management Program (CAMP) could serve as biomarkers and biologic mediators of ICS clinical response over the 4-year clinical trial period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We selected baseline serum samples from 462 CAMP subjects subsequently randomized to either ICS (budesonide) or placebo. Samples underwent small RNA sequencing, and read counts were normalized and filtered by depth and coverage. Linear regression was used to associate miRNAs with change in FEV1% (prebronchodilator FEV1 as a percent predicted) over the 4-year treatment period in both main effects and interaction models. We validated the function of the top associated miRNAs by luciferase reporter assays of glucocorticoid-mediated transrepression and predicted response to ICS through logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>We identified 7 miRNAs significantly associated with FEV1% change (P\u2009\u2264\u20090.05) and 15 miRNAs with significant interaction (P\u2009\u2264\u20090.05) to ICS versus placebo treatments. We selected three miRNAs for functional validation, of which hsa-miR-155-5p and hsa-miR-532-5p were significantly associated with changes in dexamethasone-induced transrepression of NF-\u03baB. Combined, these two miRNAs were predictive of ICS response over the course of the clinical trial, with an area under the receiver operating characteristic curve of 0.86.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified two functional circulating miRNAs predictive of asthma ICS treatment response over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201907-1454oc","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T18:03:56Z","timestamp":1586455436000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":64,"title":["Circulating MicroRNAs and Treatment Response in Childhood Asthma"],"prefix":"10.1093","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-2553","authenticated-orcid":false,"given":"Jiang","family":"Li","sequence":"first","affiliation":[{"name":"Channing Division of Network Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Panganiban","sequence":"additional","affiliation":[{"name":"Program in Molecular and Integrative Physiological Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin T.","family":"Kho","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-2712","authenticated-orcid":false,"given":"Michael J.","family":"McGeachie","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna","family":"Farnam","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Chase","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Lu","sequence":"additional","affiliation":[{"name":"Program in Molecular and Integrative Physiological Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelan G.","family":"Tantisira","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine and"},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2026030321464373000_bib1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","article-title":"Asthma","volume":"382","author":"Martinez","year":"2013","journal-title":"Lancet"},{"key":"2026030321464373000_bib2","first-page":"1","article-title":"Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010","author":"Akinbami","year":"2012","journal-title":"NCHS Data Brief"},{"key":"2026030321464373000_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ph3030514","article-title":"Inhaled corticosteroids","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026030321464373000_bib4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2026030321464373000_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321464373000_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/hmg\/ddh149","article-title":"Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids","volume":"13","author":"Tantisira","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2026030321464373000_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"2026030321464373000_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front Genet"},{"key":"2026030321464373000_bib9","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.3748\/wjg.v21.i28.8527","article-title":"Circulating RNAs as new biomarkers for detecting pancreatic cancer","volume":"21","author":"Kishikawa","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026030321464373000_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","article-title":"Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury","volume":"120","author":"Viereck","year":"2017","journal-title":"Circ Res"},{"key":"2026030321464373000_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","article-title":"Circulating microRNA is a biomarker of pediatric Crohn disease","volume":"53","author":"Zahm","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026030321464373000_bib12","doi-asserted-by":"crossref","first-page":"e0157998","DOI":"10.1371\/journal.pone.0157998","article-title":"Circulating MicroRNAs: association with lung function in asthma","volume":"11","author":"Kho","year":"2016","journal-title":"PLoS One"},{"key":"2026030321464373000_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13665-012-0026-9","article-title":"The childhood asthma management Program (CAMP): contributions to the understanding of therapy and the natural history of childhood asthma","volume":"1","author":"Covar","year":"2012","journal-title":"Curr Respir Care Rep"},{"key":"2026030321464373000_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1164\/ajrccm\/138.6.1386","article-title":"Spirometric prediction equations for Hispanic children and adults in New Mexico","volume":"138","author":"Coultas","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2026030321464373000_bib15","first-page":"725","article-title":"Changes in the normal maximal expiratory flow-volume curve with growth and aging","volume":"127","author":"Knudson","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"2026030321464373000_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","author":"Szefler","year":"2000","journal-title":"N Engl J Med"},{"key":"2026030321464373000_bib17","first-page":"352","article-title":"exceRpt: a comprehensive analytic platform for extracellular RNA profiling","volume-title":"Cell Syst","author":"Rozowsky","year":"2019"},{"key":"2026030321464373000_bib18","article-title":"preprocessCore: a collection of pre-processing functions","author":"Bolstad"},{"key":"2026030321464373000_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/bioinformatics\/btn209","article-title":"fdrtool: a versatile R package for estimating local and tail area-based false discovery rates","volume":"24","author":"Strimmer","year":"2008","journal-title":"Bioinformatics"},{"key":"2026030321464373000_bib20","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1038\/s41598-017-07565-2","article-title":"A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"2026030321464373000_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2017.11.059","article-title":"Systems biology and in vitro validation identifies family with sequence similarity 129 member A (FAM129A) as an asthma steroid response modulator","volume":"142","author":"McGeachie","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321464373000_bib22","doi-asserted-by":"crossref","first-page":"18277","DOI":"10.1074\/jbc.M601496200","article-title":"MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts","volume":"281","author":"Martin","year":"2006","journal-title":"J Biol Chem"},{"key":"2026030321464373000_bib23","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O\u2019Connell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321464373000_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2016.01.029","article-title":"Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma","volume":"137","author":"Panganiban","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321464373000_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1165\/rcmb.2011-0160OC","article-title":"Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene","volume":"47","author":"Jardim","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026030321464373000_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaci.2013.03.006","article-title":"Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults","volume":"132","author":"Pinkerton","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321464373000_bib27","doi-asserted-by":"crossref","first-page":"e0224983","DOI":"10.1371\/journal.pone.0224983","article-title":"Development and validation of exhaled breath condensate microRNAs to identify and endotype asthma in children","volume":"14","author":"Mendes","year":"2019","journal-title":"PLoS One"},{"key":"2026030321464373000_bib28","first-page":"1429","article-title":"MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung","volume-title":"J Allergy Clin Immunol","author":"Malmhall","year":"2014"},{"key":"2026030321464373000_bib29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4049\/jimmunol.1701167","article-title":"miR-155 modulates cockroach allergen- and oxidative stress-induced cyclooxygenase-2 in asthma","volume":"201","author":"Qiu","year":"2018","journal-title":"J Immunol"},{"key":"2026030321464373000_bib30","doi-asserted-by":"crossref","first-page":"E1773","DOI":"10.3390\/ijms17101773","article-title":"miR-155: a novel target in allergic asthma","volume":"17","author":"Zhou","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026030321464373000_bib31","doi-asserted-by":"crossref","first-page":"e80547","DOI":"10.1371\/journal.pone.0080547","article-title":"Dexamethasone down-regulates the expression of microRNA-155 in the livers of septic mice","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"2026030321464373000_bib32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.freeradbiomed.2012.01.031","article-title":"Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism","volume":"52","author":"Zheng","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"2026030321464373000_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","article-title":"An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses","volume":"8","author":"Mann","year":"2017","journal-title":"Nat Commun"},{"key":"2026030321464373000_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaci.2015.05.031","article-title":"Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)\/phosphoinositide 3-kinase (PI3K)\/Akt pathway in bronchial smooth muscle cells from asthmatic patients","volume":"137","author":"Alexandrova","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321464373000_bib35","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02608-15","article-title":"Human MicroRNA miR-532-5p exhibits antiviral activity against west nile virus via suppression of host genes SESTD1 and TAB3 required for virus replication","volume":"90","author":"Slonchak","year":"2015","journal-title":"J Virol"},{"key":"2026030321464373000_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000351219","article-title":"MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia","volume":"141","author":"Mosakhani","year":"2013","journal-title":"Cytogenet Genome Res"},{"key":"2026030321464373000_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/imm.12456","article-title":"MicroRNA expression profiling of human blood monocyte subsets highlights functional differences","volume":"145","author":"Dang","year":"2015","journal-title":"Immunology"},{"key":"2026030321464373000_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/tpj.2011.46","article-title":"The pharmacogenetics and pharmacogenomics of asthma therapy","volume":"11","author":"Tse","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"2026030321464373000_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-pharmtox-010814-124543","article-title":"Pharmacogenomics in asthma therapy: where are we and where do we go?","volume":"55","author":"Park","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026030321464373000_bib40","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1073\/pnas.0408532102","article-title":"TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids","volume":"101","author":"Tantisira","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321464373000_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0911353","article-title":"Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma","volume":"365","author":"Tantisira","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030321464373000_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/tpj.2012.15","article-title":"Predicting inhaled corticosteroid response in asthma with two associated SNPs","volume":"13","author":"McGeachie","year":"2013","journal-title":"Pharmacogenomics J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/1\/65\/67176529\/ajrccm_202_1_65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/1\/65\/67176529\/ajrccm_202_1_65.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:46:58Z","timestamp":1772592418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/1\/65\/8494597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201907-1454oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"2019-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}